Impact of assay procedures on detection of MR status in chronic myeloid leukemia: Optimization of cDNA synthesis. - Suppr | 超能文献

Impact of assay procedures on detection of MR status in chronic myeloid leukemia: Optimization of cDNA synthesis.

作者信息

Jeromin Sabine, Eder Christiane, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang

机构信息

MLL Munich Leukemia Laboratory, Munich, Germany.

出版信息

Int J Lab Hematol. 2019 Oct;41(5):e109-e112. doi: 10.1111/ijlh.13004. Epub 2019 Mar 12.

DOI:10.1111/ijlh.13004

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Impact of assay procedures on detection of MR status in chronic myeloid leukemia: Optimization of cDNA synthesis.

Int J Lab Hematol. 2019 Oct;41(5):e109-e112. doi: 10.1111/ijlh.13004. Epub 2019 Mar 12.

2

Chronic myeloid leukemia: Global impact from a local laboratory.

Cancer. 2017 Jul 15;123(14):2594-2596. doi: 10.1002/cncr.30776. Epub 2017 Jun 6.

3

Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia.慢性髓性白血病中BCR-ABL1激酶结构域突变的反射性筛查

Clin Lab. 2016;62(5):975-6. doi: 10.7754/clin.lab.2015.150938.

4

BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?慢性髓性白血病中的BCR-ABL1突变筛查：下一个会是现在吗？

Lancet Haematol. 2019 May;6(5):e236-e237. doi: 10.1016/S2352-3026(19)30046-8.

5

Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more.慢性粒细胞白血病的分子诊断与监测：BCR-Abl及其他

J BUON. 2009 Oct-Dec;14(4):565-73.

6

Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia.

Leuk Lymphoma. 2024 Jul;65(7):1024-1027. doi: 10.1080/10428194.2024.2331625. Epub 2024 Mar 21.

7

Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors.为什么酪氨酸激酶抑制剂无法治愈慢性髓性白血病。

Leukemia. 2021 Aug;35(8):2199-2204. doi: 10.1038/s41375-021-01272-8. Epub 2021 May 17.

8

Chronic myelogenous leukemia. Preface.慢性粒细胞白血病。前言。

Hematol Oncol Clin North Am. 2011 Oct;25(5):ix-x. doi: 10.1016/j.hoc.2011.10.001.

9

Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome.一名慢性粒细胞白血病合并克兰费尔特综合征患者持续存在的次优分子反应。

Korean J Intern Med. 2014 Nov;29(6):827-9. doi: 10.3904/kjim.2014.29.6.827. Epub 2014 Oct 31.

10

Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia.酪氨酸激酶抑制剂治疗新诊断的慢性髓性白血病

Hematol Oncol Clin North Am. 2017 Aug;31(4):577-587. doi: 10.1016/j.hoc.2017.04.006.

引用本文的文献

1

Reverse Transcription Can Critically Impact the Diagnostic Outcome of Quantitative Real-Time RT-PCR.逆转录可对定量实时逆转录聚合酶链反应的诊断结果产生关键影响。

Cancers (Basel). 2023 Aug 1;15(15):3914. doi: 10.3390/cancers15153914.

2

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.采用国际标准化检测方法比较慢性髓性白血病患者外周血和骨髓中 BCR-ABL1 定量，评估其深层分子反应。

Clin Chem Lab Med. 2020 Jul 28;58(8):1214-1222. doi: 10.1515/cclm-2019-1172.